Trials / Recruiting
RecruitingNCT05956847
The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric
The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric Cancer: an Exploratory Multicenter Prospective Observational Clinical Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
ECDNA is almost non-existent in normal cells, but exists in nearly half of human cancer cells, indicating that studying such abnormal DNA is of great significance for our understanding of tumor formation and evolution. The changes in ecDNA expression in intestinal type gastric cancer may be closely related to the occurrence and development of gastric cancer. Dynamic monitoring of changes in ecDNA expression in the gastric mucosa may help predict the occurrence of gastric cancer and guide subsequent treatment. By collaborating with multiple endoscopic centers to conduct gastroscopy biopsies on patients with gastric precancerous lesions, we aim to further explore the role of ecDNA in the occurrence and development of gastric cancer through continuous follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | gastroscopy | When performing gastroscopy, the endoscopist will perform a biopsy based on the condition of gastric mucosal lesions, with one specimen retained and the remaining specimens subjected to pathological examination |
Timeline
- Start date
- 2023-08-10
- Primary completion
- 2028-07-20
- Completion
- 2030-07-30
- First posted
- 2023-07-21
- Last updated
- 2023-08-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05956847. Inclusion in this directory is not an endorsement.